KONSTRUKT UND SEQUENZ ZUR VERBESSERTEN GENEXPRESSION

European patent · EP3089760 · In force

Register entry

Publication number
EP3089760
Application number
EP14825469
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 24, 2014
Published
Nov 9, 2016
Granted
Jan 15, 2020
Protection ends at the latest
Dec 23, 2034
Next annual fee due
Dec 31, 2026
IPC classes
C07K 16/00 (2006.01)
C07K 16/24 (2006.01)
C12P 21/00 (2006.01)
C12N 15/85 (2006.01)
C12N 15/67 (2006.01)
A61K 39/395 (2006.01)
A61K 48/00 (2006.01)
Priority
EP 13199873 31.12.2013
EP 13199875 31.12.2013
PCT application
PCT/NL2014/050907 24.12.2014
PCT publication
WO2015/102487 09.07.2015
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  3. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  4. Mar 9, 2023

    Change

    Published in Swissreg on 09.03.2023

  5. Jan 15, 2020

    Granted

    Published in Swissreg on 15.01.2020

Parties

Holder

ProteoNic Biotechnology IP B.V.

J.H. Oortweg 19-21, 2333 CH Leiden, NL

Inventor

VAN DER HEIJDEN, Maurice Wilhelmus

NL-2805 GW Gouda, NL

ENGELS, Bart Marinus

NL-3446 BB Woerden, NL

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.